UNH director receives 13-share stock grant

Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Baker Charles D. reported acquisition or exercise transactions in this Form 4 filing.

UNITEDHEALTH GROUP INC director Charles D. Baker received 13 shares of common stock as dividend equivalents on vested deferred stock units. These dividend-equivalent shares are immediately vested and carry the same terms as the underlying deferred stock units. Following this compensation-related award, Baker directly holds 2,176 shares of UnitedHealth Group common stock.

Insider Trade Summary

Grant/Award: 13 shares

Grant/Award 1 txn

Insider Baker Charles D.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	13	$0.00	$0.00

Holdings After Transaction: Common Stock — 2,176 shares (Direct)

Footnotes (1)

1. F1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Key Figures

Shares granted: 13 shares Post-transaction holdings: 2,176 shares Price per share for grant: $0.00 per share

3 metrics

Shares granted 13 shares Dividend equivalents on vested deferred stock units

Post-transaction holdings 2,176 shares Common stock directly held after award

Price per share for grant $0.00 per share Compensation-related stock grant, no cash paid

Key Terms

dividend equivalents, vested deferred stock units, Form 4

3 terms

dividend equivalents financial

"Represents dividend equivalents paid on vested deferred stock units."

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

vested deferred stock units financial

"Represents dividend equivalents paid on vested deferred stock units."

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Charles D. Baker report at UNITEDHEALTH GROUP (UNH)?

Charles D. Baker reported receiving 13 shares of UNITEDHEALTH GROUP common stock as dividend equivalents on vested deferred stock units. These shares represent a compensation-related award rather than an open-market purchase or sale, and they are immediately vested under the same terms as the underlying units.

Is Charles D. Baker’s Form 4 transaction in UNH stock a buy or a sale?

The Form 4 shows an acquisition, not a market buy or sale. Baker received 13 common shares as a grant of dividend equivalents on vested deferred stock units, a standard compensation mechanism rather than an open-market trading decision in UNITEDHEALTH GROUP shares.

How many UNITEDHEALTH GROUP (UNH) shares does Charles D. Baker hold after this Form 4?

After the reported grant, Charles D. Baker directly holds 2,176 shares of UNITEDHEALTH GROUP common stock. This total includes the additional 13 shares received as dividend equivalents on his vested deferred stock units, which were immediately vested under the same compensation terms.

What are dividend equivalents on vested deferred stock units in UNH’s Form 4?

Dividend equivalents mirror cash dividends by providing additional shares tied to deferred stock units. In this case, UNITEDHEALTH GROUP credited Charles D. Baker with 13 immediately vested common shares, subject to the same terms and conditions as his underlying vested deferred stock units.

Does this UNH Form 4 indicate any remaining stock options or derivatives for Charles D. Baker?

The filing’s derivative section is empty, indicating no derivative transactions or remaining derivative positions are reported in this Form 4 for Charles D. Baker. The only activity disclosed is the non-derivative stock grant of 13 dividend-equivalent common shares tied to deferred stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 05:37 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baker Charles D.

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MINNESOTA 55344

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2026		A		13(1)	A	$0	2,176	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Charles D. Baker	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)